This is an investigational study. Atezolizumab is FDA approved and commercially available for the treatment of non-small cell lung cancer and bladder cancer. Vemurafenib and cobimetinib are FDA approved and commercially available for the treatment of certain types of melanoma. It is investigational to give all 3 drugs in combination to patients with thyroid cancer.